Figure 5.

Silencing SNHG14 alleviates the cellular injury process of IL-1β and IL-6 in HK-2 cells via miR-93. (a–n) HK-2 cells were treated with IL-1β or IL-6 and then transfected with SNHG14 shRNAs and miR-93 inhibitor; oxidative stress (a–d), inflammation (e–h), and apoptosis (i–l) were assessed as described above; activation of NF-κB and STAT3 signaling was tested by detecting relative proteins using western blot (m, n). Data were shown as mean ± SD, ^∗P < 0.05.